The natural killer cell NKp46 receptor recognizes a ligand on pancreatic beta cells and may provide a therapeutic target against development of type 1 diabetes.
The natural killer cell NKp46 receptor recognizes a ligand on pancreatic beta cells and may provide a therapeutic target against development of type 1 diabetes.